# EPYSQLI

NDC: 51759-208
Generic name: Eculizumab-aagh
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250407

FDA application: BLA761340

## Active ingredients

- ECULIZUMAB: 300 mg/30mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51759-208"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51759-208
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1fa1aa80-1c59-44d4-9841-b6c52882651b